About URO Ltd.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Urovant Sciences GmbH
1
Clinical Trials at URO Ltd.
During the past decade, URO Ltd. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
2018-03-26
2019-02-04
Completed
1,530
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
2020-10-20
2025-06-25
Recruiting
678
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
2021-02-23
2025-09-26
Active, not recruiting
662
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "URO Ltd."
#1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at URO Ltd.
According to Clinical.Site data, the most researched conditions in "URO Ltd." are
"Cancer" (1 trials), "Overactive Bladder" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "URO Ltd." in a lesser frequency.
Clinical Trials Intervention Types at URO Ltd.
Most popular intervention types in "URO Ltd." are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Androgen deprivation therapy (ADT)" (1 trials), "Placebo" (1 trials), "Tolterodine Tartrate ER" (1 trials) and "Tolterodine placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at URO Ltd.
The vast majority of trials in "URO Ltd." are
2 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at URO Ltd.
Currently, there are NaN active trials in "URO Ltd.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in URO Ltd.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in URO Ltd., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".